Orbital exenteration

Our experience

Alessandra Di Maria, Laura Balia, Arturo Mario Poletti, Giovanni Colombo, Mary Romano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: We reviewed our experience of the multidisciplinary collaboration between ophthalmologists, head and neck surgeons, neurosurgeons, radiologists and oncologists in the management of extensive tumors treated by orbital exenteration at the Humanitas Research Institute, Milan, Italy, over the past 10 years. Methods: This is a retrospective cohort study of all patients who underwent orbital exenteration between March 2005 and August 2014 at the Humanitas Research Institute. The 10-year cohort of exenterated patients was identified through operating room notes using the clinical code set of the International Classification of Diseases, 10th revision (ICD-10). Results: A total of 26 patients were identified, including 19 (73.1%) males. The median age was 65.5 years (range 37-87). Eighteen (69.2%) patients had major skin cancers extending to the orbit. Patients were divided into 2 cohorts: cohort 1 comprising patients with sinus or craniofacial cancers requiring orbital exenteration, and cohort 2 comprising patients with advanced periorbital skin cancers. The two cohorts were well matched for sex, age at surgery, degree of invasion, extension of surgical removal, necessity of adjuvant radiotherapy, reconstruction processes, and rehabilitation. Conclusions: In our experience patients never died of the primary lesion but because of the occurrence of other problems. So we encourage local surgical radicality.

Original languageEnglish
Pages (from-to)533-535
Number of pages3
JournalTumori
Volume102
Issue number5
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Skin Neoplasms
Adjuvant Radiotherapy
International Classification of Diseases
Orbit
Operating Rooms
Italy
Neoplasms
Cohort Studies
Neck
Rehabilitation
Retrospective Studies
Head
Ophthalmologists
Surgeons
Oncologists
Radiologists
Neurosurgeons

Keywords

  • Cancer therapy
  • Craniofacial cancer
  • Orbital exenteration
  • Tumors

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Di Maria, A., Balia, L., Poletti, A. M., Colombo, G., & Romano, M. (2016). Orbital exenteration: Our experience. Tumori, 102(5), 533-535. https://doi.org/10.5301/tj.5000434

Orbital exenteration : Our experience. / Di Maria, Alessandra; Balia, Laura; Poletti, Arturo Mario; Colombo, Giovanni; Romano, Mary.

In: Tumori, Vol. 102, No. 5, 01.09.2016, p. 533-535.

Research output: Contribution to journalArticle

Di Maria, A, Balia, L, Poletti, AM, Colombo, G & Romano, M 2016, 'Orbital exenteration: Our experience', Tumori, vol. 102, no. 5, pp. 533-535. https://doi.org/10.5301/tj.5000434
Di Maria A, Balia L, Poletti AM, Colombo G, Romano M. Orbital exenteration: Our experience. Tumori. 2016 Sep 1;102(5):533-535. https://doi.org/10.5301/tj.5000434
Di Maria, Alessandra ; Balia, Laura ; Poletti, Arturo Mario ; Colombo, Giovanni ; Romano, Mary. / Orbital exenteration : Our experience. In: Tumori. 2016 ; Vol. 102, No. 5. pp. 533-535.
@article{b3101b2c6c18439d923bfe2f3325e3b5,
title = "Orbital exenteration: Our experience",
abstract = "Introduction: We reviewed our experience of the multidisciplinary collaboration between ophthalmologists, head and neck surgeons, neurosurgeons, radiologists and oncologists in the management of extensive tumors treated by orbital exenteration at the Humanitas Research Institute, Milan, Italy, over the past 10 years. Methods: This is a retrospective cohort study of all patients who underwent orbital exenteration between March 2005 and August 2014 at the Humanitas Research Institute. The 10-year cohort of exenterated patients was identified through operating room notes using the clinical code set of the International Classification of Diseases, 10th revision (ICD-10). Results: A total of 26 patients were identified, including 19 (73.1{\%}) males. The median age was 65.5 years (range 37-87). Eighteen (69.2{\%}) patients had major skin cancers extending to the orbit. Patients were divided into 2 cohorts: cohort 1 comprising patients with sinus or craniofacial cancers requiring orbital exenteration, and cohort 2 comprising patients with advanced periorbital skin cancers. The two cohorts were well matched for sex, age at surgery, degree of invasion, extension of surgical removal, necessity of adjuvant radiotherapy, reconstruction processes, and rehabilitation. Conclusions: In our experience patients never died of the primary lesion but because of the occurrence of other problems. So we encourage local surgical radicality.",
keywords = "Cancer therapy, Craniofacial cancer, Orbital exenteration, Tumors",
author = "{Di Maria}, Alessandra and Laura Balia and Poletti, {Arturo Mario} and Giovanni Colombo and Mary Romano",
year = "2016",
month = "9",
day = "1",
doi = "10.5301/tj.5000434",
language = "English",
volume = "102",
pages = "533--535",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Orbital exenteration

T2 - Our experience

AU - Di Maria, Alessandra

AU - Balia, Laura

AU - Poletti, Arturo Mario

AU - Colombo, Giovanni

AU - Romano, Mary

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Introduction: We reviewed our experience of the multidisciplinary collaboration between ophthalmologists, head and neck surgeons, neurosurgeons, radiologists and oncologists in the management of extensive tumors treated by orbital exenteration at the Humanitas Research Institute, Milan, Italy, over the past 10 years. Methods: This is a retrospective cohort study of all patients who underwent orbital exenteration between March 2005 and August 2014 at the Humanitas Research Institute. The 10-year cohort of exenterated patients was identified through operating room notes using the clinical code set of the International Classification of Diseases, 10th revision (ICD-10). Results: A total of 26 patients were identified, including 19 (73.1%) males. The median age was 65.5 years (range 37-87). Eighteen (69.2%) patients had major skin cancers extending to the orbit. Patients were divided into 2 cohorts: cohort 1 comprising patients with sinus or craniofacial cancers requiring orbital exenteration, and cohort 2 comprising patients with advanced periorbital skin cancers. The two cohorts were well matched for sex, age at surgery, degree of invasion, extension of surgical removal, necessity of adjuvant radiotherapy, reconstruction processes, and rehabilitation. Conclusions: In our experience patients never died of the primary lesion but because of the occurrence of other problems. So we encourage local surgical radicality.

AB - Introduction: We reviewed our experience of the multidisciplinary collaboration between ophthalmologists, head and neck surgeons, neurosurgeons, radiologists and oncologists in the management of extensive tumors treated by orbital exenteration at the Humanitas Research Institute, Milan, Italy, over the past 10 years. Methods: This is a retrospective cohort study of all patients who underwent orbital exenteration between March 2005 and August 2014 at the Humanitas Research Institute. The 10-year cohort of exenterated patients was identified through operating room notes using the clinical code set of the International Classification of Diseases, 10th revision (ICD-10). Results: A total of 26 patients were identified, including 19 (73.1%) males. The median age was 65.5 years (range 37-87). Eighteen (69.2%) patients had major skin cancers extending to the orbit. Patients were divided into 2 cohorts: cohort 1 comprising patients with sinus or craniofacial cancers requiring orbital exenteration, and cohort 2 comprising patients with advanced periorbital skin cancers. The two cohorts were well matched for sex, age at surgery, degree of invasion, extension of surgical removal, necessity of adjuvant radiotherapy, reconstruction processes, and rehabilitation. Conclusions: In our experience patients never died of the primary lesion but because of the occurrence of other problems. So we encourage local surgical radicality.

KW - Cancer therapy

KW - Craniofacial cancer

KW - Orbital exenteration

KW - Tumors

UR - http://www.scopus.com/inward/record.url?scp=84995642293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995642293&partnerID=8YFLogxK

U2 - 10.5301/tj.5000434

DO - 10.5301/tj.5000434

M3 - Article

VL - 102

SP - 533

EP - 535

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -